Literature DB >> 5549716

Suppression of an antibody to factor VIII by a combination of factor VIII and cyclophosphamide.

D Green.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5549716

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomes.

Authors:  Amy D Shapiro; Ulla Hedner
Journal:  Ther Adv Drug Saf       Date:  2011-10

Review 2.  Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

3.  Cyclophosphamide inhibition of insulin antibody production, insulin resistance and experimental immunodiabetes.

Authors:  L Korcáková; M Titlbach; K Nouza
Journal:  Acta Diabetol Lat       Date:  1972 Nov-Dec

4.  Acute abdominal pain due to an acquired disorder of coagulation.

Authors:  V Roy; M L Tillyer; B T Colvin
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-21

5.  Acquired haemophilia A as a blood transfusion emergency.

Authors:  Giuseppe Tagariello; Roberto Sartori; Paolo Radossi; Renzo Risato; Giovanni Roveroni; Cristina Tassinari; Annachiara Giuffrida; Giorgio Gandini; Massimo Franchini
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

6.  Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: treatment with intravenous immunoglobulin. A case report.

Authors:  A Gianella-Borradori; A Hirt; A Lüthy; H P Wagner; P Imbach
Journal:  Blut       Date:  1984-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.